BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1918424)

  • 1. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients.
    Zimmer B; Rosen J; Thornton JE; Perel JM; Reynolds CF
    J Clin Psychopharmacol; 1991 Aug; 11(4):254-6. PubMed ID: 1918424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression.
    Flint AJ; Rifat SL
    J Clin Psychopharmacol; 1994 Oct; 14(5):353-6. PubMed ID: 7806693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK; Vegt M; Nolen WA
    Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome.
    Papakostas GI; Petersen T; Pava J; Masson E; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
    J Nerv Ment Dis; 2003 Jul; 191(7):444-9. PubMed ID: 12891091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A; Ginath Y
    Harefuah; 1991 Dec; 121(11):429-30. PubMed ID: 1786889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.
    Flint AJ; Rifat SL
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):23-8. PubMed ID: 9489577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation.
    Thase ME; Kupfer DJ; Frank E; Jarrett DB
    J Clin Psychiatry; 1989 Nov; 50(11):413-7. PubMed ID: 2509437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid response of patients simultaneously treated with lithium and nortriptyline.
    Austin LS; Arana GW; Ballenger JC
    J Clin Psychiatry; 1990 Mar; 51(3):124-5. PubMed ID: 2407731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.
    Fabre LF; Scharf MB; Itil TM
    J Clin Psychiatry; 1991 Jun; 52 Suppl():62-7. PubMed ID: 2050651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
    Kok RM; Nolen WA; Heeren TJ
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium.
    Dorée JP; Des Rosiers J; Lew V; Gendron A; Elie R; Stip E; Tourjman SV
    Curr Med Res Opin; 2007 Feb; 23(2):333-41. PubMed ID: 17288688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine.
    Strober M; Freeman R; Rigali J; Schmidt S; Diamond R
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):16-20. PubMed ID: 1537769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G
    Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study.
    Zusky PM; Biederman J; Rosenbaum JF; Manschreck TC; Gross CC; Weilberg JB; Gastfriend DR
    J Clin Psychopharmacol; 1988 Apr; 8(2):120-4. PubMed ID: 3131389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.